Tag: ISC

tranexamic acid ICH reduction

ISC News: Trend toward benefit in using blood-clotting agent to treat...

Treatment with tranexamic acid, a common medication that reduces bleeding, has led to a non-statistically significant reduction in intracerebral haemorrhage (ICH) growth, both in...
AUGUSTUS

ISC News: AUGUSTUS secondary analysis confirms safety of blood thinning agent

Treatment with the blood thinner apixaban was associated with a lower risk of bleeding, death and hospitalisation compared with warfarin, regardless of history of...

ISC News: Non-inferiority for direct mechanical thrombectomy “could not be proven”

Skipping IV thrombolysis and using mechanical clot removal alone for stroke was not shown to be non-inferior compared to the combination of both treatments,...
mobile stroke unit

Live from ISC: Fast treatment via mobile stroke unit found to...

Treating stroke patients in specialised ambulances speeds treatment and reduces patients’ disability, according to late-breaking science presented at the International Stroke Conference (ISC; 19–21...

Brain stents are safe and effective for reducing recurrent stroke risk,...

A brain stent appears safe and effective for reducing the risk of recurrent stroke in patients with cholesterol-clogged brain arteries, according to late-breaking data...
wearable brain stimulation

Live from ISC: Wearable brain stimulation could safely improve motor function...

A new, non-invasive wearable magnetic brain stimulation device to improve recovery for stroke survivors has been deemed safe and effective. David Chiu, director of...
endovascular access Amrou Sarraj

Live from ISC: Study finds endovascular therapy access within 15 minutes...

Current direct endovascular therapy access for acute ischaemic stroke within 15 minutes is limited to one-fifth of the US population, concludes a recent...
artificial intelligence

Viz.ai adds new capabilities to its AI stroke platform

Viz.ai has launched the next generation of its synchronized care platform for stroke. Viz.ai incorporates cutting edge artificial intelligence with HIPAA-compliant communication to allow...

ISC News: Blacks, Hispanics of Caribbean descent have higher stroke risk...

Both Blacks and Hispanics of Caribbean descent living in Northern Manhattan have a significantly higher risk of stroke than their non-Hispanic, white neighbours, according...

The efficacy of endovascular stroke therapy outside of specialised centres needs...

Real-world data investigating patient outcome after endovascular stroke therapy in high versus low volume centres finds a 30% increase in the likelihood of a...

Presented at the ISC: PHAST-TSC trial for treatment of acute stroke

Following the American Heart Association’s International Stroke Conference (ISC; 5–8 February, Hawaii, USA), Diffusion Pharmaceuticals announce a poster presented at the conference, outlining the...

Neurologists speak out about gender disparity at global stroke gathering

The International Stroke Conference (ISC) attracts thousands of neurologists each year to network with fellow experts and watch compelling presentations on the very latest...

CT perfusion core volume and time found strongly associated with EVT...

The likelihood of good clinical and safety outcomes after endovascular thrombectomy in patients with large core on CT ASPECTS (Alberta stroke programme early CT...

Standard treatment of hyperglycaemia in acute ischaemic stroke outperforms an intensive...

  Intensive glucose control (80–130mg/dL) does not improve 90-day functional outcome and increases the risk of severe hypoglycaemia. This is the conclusion presented by Karen...

Patrick Lyden receives eminent American Stroke Association Award

Patrick D Lyden, a world-renowned stroke expert who played a key role in the pivotal clinical trial leading to approval of the first proven...
EmboTrap (Neuravi/Johnson and Johnson’s Cerenovus) achieved a high reperfusion rate among acute ischaemic stroke patients with large vessel occlusion. With three, or fewer, passes of the device, 80.2% patients in the study achieved mTICI 2b–3 grade revascularisation in the target vessel. The results were presented at International Stroke Conference (ISC; 24–26 January 2018, Los Angeles, USA)

ARISE II results show two-thirds of ischaemic stroke patients return to...

EmboTrap (Neuravi/Johnson and Johnson’s Cerenovus) achieved a high reperfusion rate among acute ischaemic stroke patients with large vessel occlusion. With three, or fewer, passes...

New ischaemic stroke guidelines widen mechanical thrombectomy window to 24 hours...

The American Heart Association and American Stroke Association released updated ischaemic stroke guidelines that were published in Stroke, and released during the International Stroke...

“Aspiration first” approach with Penumbra system demonstrates favourable outcomes for acute...

Penumbra announced results of the company-sponsored PROMISE study, demonstrating real-world safety and efficacy of the Penumbra system with ACE 68 and ACE64 reperfusion catheters...

Hydrogel coils beat bare platinum in comparison study

The GREAT randomised controlled trial has confirmed that better outcomes can be achieved with hydrogel coils compared to bare platinum coils for the treatment...

Bleeding stroke survivors at higher risk of depression, dementia

People who survive brain bleeds are at significantly higher risk of later developing depression and dementia, according to research presented at the American Stroke...